paromomycin Gene Set

Dataset LINCS L1000 CMAP Chemical Perturbation Consensus Signatures
Category transcriptomics
Type small molecule perturbation
Description An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. (Chemical Entities of Biological Interest Ontology, CHEBI_7934)
Similar Terms
Downloads & Tools

Genes

10 genes differentially expressed following the paromomycin small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset.

increased expression

Symbol Name Standardized Value
NAT2 N-acetyltransferase 2 (arylamine N-acetyltransferase) 3.75943
MPHOSPH10 M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) 3.73727
EPHB2 EPH receptor B2 3.5341
TAS2R10 taste receptor, type 2, member 10 3.51867
PAN2 PAN2 poly(A) specific ribonuclease subunit 3.29794
CCN6 cellular communication network factor 6 3.26855
IFNAR1 interferon (alpha, beta and omega) receptor 1 3.20098

decreased expression

Symbol Name Standardized Value
CDC42 cell division cycle 42 -4.37912
MYOZ3 myozenin 3 -3.18009
PGC progastricsin (pepsinogen C) -3.17028